NeueHealth, Inc. (NYSE:NEUE) Q4 2024 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
Despite reporting a strong year of financial performance, the significant EPS miss and lack of a shareholder return plan overshadow positive aspects. The Q&A highlighted growth and profitability in some areas but also revealed challenges and uncertainties, especially in the NeueSolutions segment. The acquisition by NEA may provide long-term benefits, but the immediate impact of the earnings miss and financial instability is likely to result in a negative stock price reaction in the short term.
Key Financial Performance
Earnings Per Share (EPS) Reported EPS is $-7.41, a decrease from expectations of $-2.29, indicating a significant miss on earnings expectations.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Financial Performance: Delivered strongest year of financial performance to date in 2024.
Care Model: Refined a care model that aligns with the industry’s shift towards value-based care.
Consumer Engagement: Focus on proactively managing care through key consumer engagement and care management initiatives.
Market Positioning: Positioned as a strong alternative to episodic transactional care.
Consumer-Centric Approach: Committed to placing the consumer at the center of operations, developing a holistic understanding of every person served.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Earnings Miss: NeueHealth reported an EPS of $-7.41, significantly missing expectations of $-2.29, indicating potential financial instability.
Regulatory Risks: The company acknowledges risks and uncertainties related to forward-looking statements, which may impact future performance.
Market Competition: The shift towards value-based care presents competitive pressures as NeueHealth positions itself against traditional episodic care models.
Consumer Engagement Challenges: The focus on consumer engagement and care management initiatives may face challenges in effectively empowering consumers and managing care.
Economic Factors: The overall economic environment may affect the company's ability to maintain financial performance and growth.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Care Model Development: NeueHealth has created and refined a care model that aligns with the industry's shift towards value-based care, focusing on long-standing trusted relationships in local communities.
Consumer-Centric Approach: The company is committed to placing the consumer at the center of its operations, developing a holistic understanding of each individual served.
Proactive Care Management: Focus on key consumer engagement and care management initiatives to drive better health outcomes.
Financial Performance: NeueHealth reported its strongest year of financial performance to date in 2024, setting a solid foundation for growth in 2025 and beyond.
Future Growth: The company aims to continue expanding relationships with payer and provider partners and advancing its care model.
Earnings Expectations: The reported EPS for Q4 2024 was $-7.41, missing expectations of $-2.29.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What are the key growth metrics for NeueHealth in 2024?
A:In 2024, we served 483,000 consumers, representing a compound annual growth rate of 123% since 2020. We have already grown to serve 717,000 consumers at the start of 2025, with a 31% increase through existing payer relationships and a 97% increase in recently expanded markets.
Q:Can you provide details on the financial performance for the fourth quarter and full year?
A:The fourth quarter consolidated revenue was $232.6 million, and full year consolidated revenue was $936.7 million. We achieved adjusted EBITDA profitability for the fourth consecutive quarter, with $5.5 million in the fourth quarter and $22.5 million for the full year.
Q:What are the future plans for NeueHealth in 2025?
A:In 2025, we plan to continue diversifying the populations we serve, deepen our presence in local communities, grow alongside our payer partners, and strengthen partnerships with providers.
Q:What is the status of the acquisition by NEA?
A:We announced a definitive agreement to be acquired by NEA, which will make NeueHealth a privately held company. We anticipate the transaction closing in the second quarter of 2025.
Q:What are the challenges faced in the NeueSolutions segment?
A:The NeueSolutions segment had an operating loss of $5.3 million for the full year, indicating challenges in profitability despite revenue growth.
Q:Review of Unclear Management Responses
A:Management did not provide specific details on the challenges faced in the NeueSolutions segment, particularly regarding the operating loss and how they plan to address it.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
CFO statement
Carlin today
Conference name
Conference reminder
Inc expectation
NeueHealth Conference
NeueHealth Inc
Transcript NeueHealth
amount measure
expectation NeueHealth
floor NeueHealth
host floor
law statement
measure reconciliation
name Carlin
presentation Investor
security law
statement security
today host
NEUE Transcript
NeueHealth, Inc. (NYSE:NEUE) Q4 2024 Earnings Call Transcript
Unknown3-22
Despite reporting a strong year of financial performance, the significant EPS miss and lack of a shareholder return plan overshadow positive aspects. The Q&A highlighted growth and profitability in some areas but also revealed challenges and uncertainties, especially in the NeueSolutions segment. The acquisition by NEA may provide long-term benefits, but the immediate impact of the earnings miss and financial instability is likely to result in a negative stock price reaction in the short term.
NeueHealth, Inc (NEUE) Q4 2024 Earnings Call Transcript
Neutral3-20
NeueHealth, Inc (NEUE) Q4 2024 Earnings Call Transcript
Unknown3-20
The earnings call reveals strong financial performance, with revenue and EBITDA growth, and a solid cash position. However, the acquisition announcement and pending transition to a private entity may cause uncertainty. Additionally, management's vague responses in the Q&A, especially regarding supply chain challenges and the new product launch timeline, may concern investors. The acquisition and regulatory risks further temper the positive financial results. Given these mixed signals and the lack of market cap data, a neutral stock price movement is predicted.
NeueHealth, Inc. (NEUE) Q3 2024 Earnings Conference Call Transcript
Unknown11-10
The earnings call summary presents a mixed picture: strong consumer growth and solid financial performance, but challenges with ACA insurance wind-down and economic uncertainties. The Q&A section lacks clarity, failing to address concerns adequately. Despite positive EBITDA and revenue growth, the lack of new partnerships or strong guidance adjustments limits positive sentiment. The market may react neutrally over the next two weeks, as strengths are balanced by risks and uncertainties.
NEUE Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
